| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |